Warfarin may protect against common cancers
Warfarin may protect against common cancers, an observational study suggests.
The population-based study of more than 1.2 million over-50s shows a “remarkable association” between warfarin use and lower cancer incidence, say the researchers from Norway.
Their review, based on national registry data over a seven-year period, found that warfarin users had a 16% reduced risk of all cancers after a minimum two-year interval, compared with non-users.
Looking at organ-specific sites, warfarin use was linked with a 31% reduced risk of prostate cancer, a 20% reduced risk of lung